Research & Development
At PRI, we are engaged in three key areas of Research & Development:
- Drug Discovery at PRI reaches across therapeutic areas: hematology, oncology, cardiovascular, ophthalmology, vascular diseases, neurology, and inflammation.
- Drug Development at PRI includes drug formulation (particularly nanoformulation) and stability testing, leading to clinical trials.
- Nanotechnology/Biotechnology at PRI covers a wide range of applications. An example PRI’s nanobiotechnology approach is targeted delivery of nanoparticles loaded with chemotherapeutic agents for pancreatic, brain, breast, prostate, ovarian, and lung cancer.